Cargando…
Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types
Paclitaxel, the most commonly used form of chemotherapy, is utilized in curative protocols in different types of cancer. The response to treatment differs among patients. Biological interpretation of a mechanism to explain this personalized response is still unavailable. Since paclitaxel is known to...
Autores principales: | Ben-Hamo, Rotem, Zilberberg, Alona, Cohen, Helit, Bahar-Shany, Keren, Wachtel, Chaim, Korach, Jacob, Aviel-Ronen, Sarit, Barshack, Iris, Barash, Danny, Levanon, Keren, Efroni, Sol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478919/ https://www.ncbi.nlm.nih.gov/pubmed/31044156 http://dx.doi.org/10.1038/s41698-019-0084-3 |
Ejemplares similares
-
hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elements
por: Ben-Hamo, Rotem, et al.
Publicado: (2015) -
SENP5 mediates breast cancer invasion via a TGFβRI SUMOylation cascade
por: Cashman, Rivki, et al.
Publicado: (2014) -
CCNE1 expression in high grade serous carcinoma does not correlate with chemoresistance
por: Sapoznik, Stav, et al.
Publicado: (2017) -
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer
por: Cohen, Helit, et al.
Publicado: (2014) -
Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis
por: Sapoznik, Stav, et al.
Publicado: (2016)